Showing results (1231-1240 of 1,243) with videos related to

Sort By:
Pageof 125
FEMS Immunology and Medical Microbiology|November 13, 2007
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agentsChris Druar, Fei Yu, Jodie L Barnes, et al.
Nature|June 6, 2000
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) ConsortiumA Smahi, G Courtois, P Vabres, et al.
ACS Nano|May 18, 2017
Quantum Dot-Peptide-Fullerene Bioconjugates for Visualization of in Vitro and in Vivo Cellular Membrane PotentialOkhil K Nag, Michael H Stewart, Jeffrey R Deschamps, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|August 22, 2022
The Royal Canadian Mounted Police (RCMP) Study: protocol for a prospective investigation of mental health risk and resilience factorsR Nicholas Carleton, Gregory P Krätzig, Shannon Sauer-Zavala, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 29, 2017
Mental Disorder Symptoms among Public Safety Personnel in CanadaR Nicholas Carleton, Tracie O Afifi, Sarah Turner, et al.
Molecular Syndromology|December 6, 2011
Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 MicroduplicationsJ Wincent, D L Bruno, B W M van Bon, et al.
Comprehensive Psychiatry|February 9, 2025
Mental health disorder symptom changes among public safety personnel after emotional resilience skills trainingR N Carleton, S Sauer-Zavala, T A Teckchandani, et al.
American Heart Journal|November 14, 2025
Rationale for and design of the REsolution of LEft VENTricular thrombus (RELEVENT) TrialGraham S Hillis, Jarryd S K Walker, Thomas Gilbert, et al.
American Journal of Public Health|March 18, 2021
Mass SARS-CoV-2 Testing in a Dormitory-Style Correctional Facility in ArkansasLindsay K Tompkins, Jayleen K L Gunn, Blake Cherney, et al.
Clinical Genitourinary Cancer|December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Pageof 125